Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide plus intensive insulin vs intensive insulin in elderly critically ill patients with hyperglycemia
ChiCTR2400089328Phase 4Not yet recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Sep 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of liraglutide in hyperglycemia (2 arms), sponsored by Xiangyang Central Hospital. Primary endpoints: 72-hour mean blood glucose and Coefficient of variation of blood glucose over 72 hours. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on ChiCTR2400089328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089328.